Skip to main content
. 2020 Oct 30;1:11. doi: 10.1186/s43556-020-00014-z

Table 2.

Excipients used in marketed inhaled protein formulations

Product Device type Active Pharmaceutical Ingredient (API) Excipients
Pulmozyme® (approved 1993) Jet nebuliser Dornase alfa (DNase I) sodium chloride, calcium chloride dihydrate
Exubera® (approved 2006, discontinued 2007) DPI Insulin human mannitol, sodium citrate, glycine, sodium hydroxide
Afrezza® (approved 2014) DPI Insulin human fumaryl diketopiperazine, polysorbate 80